IPHARMA ADVISORY BOARD
David Mead (iPharma 2020)
CEO & Cofounder, Varigen Biosciences, USA
David Mead is CEO and Co-Founder of Varigen Biosciences Corp and founder of Lucigen Corp. Dr. Mead earned a Ph.D. in Physiology and Biophysics at the University of Illinois–Champaign/Urbana, and is co-author of sixty publications, co-inventor on ten patents, and the inventor of TA cloning.
Istvan J Enyedy (iPharma 2020)
Istvan J Enyedy has been working at Biogen Idec, in Cambridge MA. He received his PhD in 1998 at Catholic University of America, Washington DC, and did postdoctoral training in Dr. Shaomeng Wang’s group at Georgetown University Medical Center, Washington DC. Between 2001 and 2008 he worked at Bayer Pharmaceuticals, West Haven CT and Novartis Institutes for Biomedical Research in Cambridge MA. In the past 21 years.
Rosemarie Truman (iPharma 2020)
Founder and CEO of the Center for Advancing Innovation (CAI), UK
Rosemarie Truman is an entrepreneur, growth strategist, distinguished corporate executive, angel investor and prolific startup catalyst. Rosemarie’s specialty is growth and investment strategy, having led growth strategies for 50 of the global Fortune 100 companies in over 15 countries. Under Rosemarie’s leadership, CAI has earned numerous awards and recognition from Health and Human Services, the White House, the Federal Laboratory Consortium and more.
Klara Valko (iPharma 2020)
Director, Bio-Mimetic Chromatography Ltd, UK
Klara Valko has completed his PhD at the age of 26 years from Semmelweis University and postdoctoral studies from Yale University, CT, USA. After working at GSK for 22 years now she is the director of Bio-Mimetic Chromatography Ltd, providing consultations and measurement services for biotech companies involved in drug discovery. She has published more than 100 papers in reputed journals and she is a Fellow of the Royal Society of Chemistry.
Farid Menaa (iPharma 2020)
California Innovations Corporation, USA
Dr. Farid Menaa, Professor, Director and Independent Consultant, California Innovations Corporation, CA, USA. Worked as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations in the field of medicine, science, technology and business, including in the nano-segment.